Literature DB >> 3487030

Localisation of the monocyte-binding region on human immunoglobulin G.

J M Woof, L J Partridge, R Jefferis, D R Burton.   

Abstract

Earlier studies, which provided indirect evidence for the involvement of the C gamma 2 domain of human immunoglobulin G (IgG) in human immunoglobulin G (IgG) in human monocyte binding, have been extended to further localise the site of interaction on human IgG. A number of IgGs from several different species and fragments of human IgGs were assayed for ability to inhibit the interaction of radio-labelled human IgG and the human monocyte. By comparison of the amino-acid sequences of those IgGs found to exhibit relatively tight, intermediate or weak binding to human monocyte Fc receptors we are able to postulate a possible monocyte-binding site on human IgG. In addition, the results have implications for the applicability of monoclonal antibodies and antisera when used in the presence of human monocytes and possibly macrophages.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3487030     DOI: 10.1016/0161-5890(86)90059-3

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  32 in total

Review 1.  Functions of the Fc receptors for immunoglobulin G.

Authors:  B K Flesch; J Neppert
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Monocyte-bound monoclonal antibodies inhibit the Fc gamma RI-mediated phagocytosis of sensitized red cells: the efficiency and mechanism of inhibition are determined by the nature of the antigen.

Authors:  S L Shepard; A G Hadley
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

3.  Distinctive role of IgG1 and IgG3 isotypes in Fc gamma R-mediated functions.

Authors:  Z Rozsnyay; G Sármay; M Walker; K Maslanka; Z Valasek; R Jefferis; J Gergely
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

4.  Identification of the Fc gamma receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies.

Authors:  M S Chappel; D E Isenman; M Everett; Y Y Xu; K J Dorrington; M H Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

5.  Engineering an improved IgG4 molecule with reduced disulfide bond heterogeneity and increased Fab domain thermal stability.

Authors:  Shirley J Peters; C Mark Smales; Alistair J Henry; Paul E Stephens; Shauna West; David P Humphreys
Journal:  J Biol Chem       Date:  2012-05-18       Impact factor: 5.157

6.  Survival of immunoglobulin G-opsonized Toxoplasma gondii in nonadherent human monocytes.

Authors:  C E Fadul; J Y Channon; L H Kasper
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

7.  Differences between the activities of human monoclonal IgG1 and IgG3 subclasses of anti-D(Rh) antibody in their ability to mediate red cell-binding to macrophages.

Authors:  E Wiener; A Atwal; K M Thompson; M D Melamed; B Gorick; N C Hughes-Jones
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

8.  Comparison of human monocytes isolated by elutriation and adherence suggests that heterogeneity may reflect a continuum of maturation/activation states.

Authors:  I Dransfield; D Corcoran; L J Partridge; N Hogg; D R Burton
Journal:  Immunology       Date:  1988-03       Impact factor: 7.397

9.  Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1.

Authors:  M Hezareh; A J Hessell; R C Jensen; J G van de Winkel; P W Parren
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

10.  The functional activity of Fc gamma RII and Fc gamma RIII on subsets of human lymphocytes.

Authors:  A G Hadley; B Zupanska; B M Kumpel; K A Leader
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.